IP Library Granted Patent US 9,839,691
Granted Patent B2
US 9,839,691 · App. 14/857,192 · Granted Dec 12, 2017

Methods of treating pancreatic and ovarian cancers using compositions containing an ion pair of a lipoic acid derivative

Inventors: Robert G. L. Shorr (Edison, NJ); Robert J. Rodriguez (West Windsor, NJ); Rajinder Bhasin (Coram, NY)
Assignee: RAFAEL PHARMACEUTICALS, INC.
A61K47/18A61K31/19A61K31/20A61K31/381A61K45/06A61K47/183A61K47/22A61K47/36A61K47/4803
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,839,691
App. No.
14/857,192
Granted
Dec 12, 2017
Kind
B2
Abstract

Pharmaceutical formulations containing lipoic acid derivatives and ion pairs thereof are described. The pharmaceutical formulations are useful in the treatment of medical disorders, such as cancer.

Claims (16)

1. A method of treating a cancer of the pancreas or ovary in a patient, comprising administering to a patient in need thereof a pharmaceutical formulation comprising:

(a) a compound of Formula I:

(b) triethanolamine; and

(c) a pharmaceutically acceptable diluent;

wherein the compound of Formula I and triethanolamine form an ion pair.

2. The method of claim 1 , wherein the triethanolamine and the compound of Formula I is present in a ratio ranging from 20:1 to 1:20.

3. The method of claim 1 , wherein the ion pair is present in the pharmaceutical formulation in an amount to provide from 0.001 mg/m 2 to 10 g/m 2 of the compound of Formula I upon administration of the pharmaceutical formulation to the patient.

4. The method of claim 1 , wherein the diluent is selected from the group consisting of saline, a sugar solution, an alcohol, dimethylformamide, dimethylsulfoxide, dimethylacetamide, and combinations thereof.

5. The method of claim 1 , wherein the diluent is a dextrose solution.

6. The method of claim 5 , wherein the dextrose solution contains an amount of dextrose ranging from 2.5% to 10% by weight.

7. The method of claim 1 , wherein the cancer is a cancer of the pancreas.

8. The method of claim 2 , wherein the cancer is a cancer of the pancreas.

9. The method of claim 5 , wherein the cancer is a cancer of the pancreas.

10. The method of claim 1 , wherein the cancer is a cancer of the ovary.

11. The method of claim 2 , wherein the cancer is a cancer of the ovary.

12. The method of claim 5 , wherein the cancer is a cancer of the ovary.

Assignments (2)
CHANGE OF NAME Recorded Aug 17, 2017
From: CORNERSTONE PHARMACEUTICALS, INC.
To: RAFAEL PHARMACEUTICALS, INC.
Reel/Frame 043582/0850 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2017
From: SHORR, ROBERT G. L.; RODRIGUEZ, ROBERT J.; BHASIN, RAJINDER
To: CORNERSTONE PHARMACEUTICALS, INC.
Reel/Frame 043104/0161 →
Continuity (5)
Continuation 13569654 · Aug 8, 2012
Continuation 12604763 · Oct 23, 2009
Continuation In Part 12105100 · Apr 17, 2008
Provisional Application 60912605 · Apr 18, 2007
Related Publication 20160220678A1 · Aug 4, 2016